These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

418 related articles for article (PubMed ID: 34031601)

  • 21. Degenerated Cones in Cultured Human Retinas Can Successfully Be Optogenetically Reactivated.
    Kamar S; Howlett MHC; Klooster J; Graaff W; Csikós T; Rabelink MJWE; Hoeben RC; Kamermans M
    Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31947650
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Restoring the ON Switch in Blind Retinas: Opto-mGluR6, a Next-Generation, Cell-Tailored Optogenetic Tool.
    van Wyk M; Pielecka-Fortuna J; Löwel S; Kleinlogel S
    PLoS Biol; 2015 May; 13(5):e1002143. PubMed ID: 25950461
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Proinsulin slows retinal degeneration and vision loss in the P23H rat model of retinitis pigmentosa.
    Fernández-Sánchez L; Lax P; Isiegas C; Ayuso E; Ruiz JM; de la Villa P; Bosch F; de la Rosa EJ; Cuenca N
    Hum Gene Ther; 2012 Dec; 23(12):1290-300. PubMed ID: 23017108
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mini-Review: Cell Type-Specific Optogenetic Vision Restoration Approaches.
    Chaffiol A; Duebel J
    Adv Exp Med Biol; 2018; 1074():69-73. PubMed ID: 29721929
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Restoring vision using optogenetics without being blind to the risks.
    Harris AR; Gilbert F
    Graefes Arch Clin Exp Ophthalmol; 2022 Jan; 260(1):41-45. PubMed ID: 34724112
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Optogenetic Therapy for Visual Restoration.
    Sakai D; Tomita H; Maeda A
    Int J Mol Sci; 2022 Nov; 23(23):. PubMed ID: 36499371
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Optogenetic Strategies for Vision Restoration.
    Lu Q; Pan ZH
    Adv Exp Med Biol; 2021; 1293():545-555. PubMed ID: 33398841
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Restoration of visual function by transplantation of optogenetically engineered photoreceptors.
    Garita-Hernandez M; Lampič M; Chaffiol A; Guibbal L; Routet F; Santos-Ferreira T; Gasparini S; Borsch O; Gagliardi G; Reichman S; Picaud S; Sahel JA; Goureau O; Ader M; Dalkara D; Duebel J
    Nat Commun; 2019 Oct; 10(1):4524. PubMed ID: 31586094
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Retinal optogenetic therapies: clinical criteria for candidacy.
    Jacobson SG; Sumaroka A; Luo X; Cideciyan AV
    Clin Genet; 2013 Aug; 84(2):175-82. PubMed ID: 23590195
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mutation-Independent Gene Therapies for Rod-Cone Dystrophies.
    Fortuny C; Flannery JG
    Adv Exp Med Biol; 2018; 1074():75-81. PubMed ID: 29721930
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of retinitis pigmentosa due to MERTK mutations by ocular subretinal injection of adeno-associated virus gene vector: results of a phase I trial.
    Ghazi NG; Abboud EB; Nowilaty SR; Alkuraya H; Alhommadi A; Cai H; Hou R; Deng WT; Boye SL; Almaghamsi A; Al Saikhan F; Al-Dhibi H; Birch D; Chung C; Colak D; LaVail MM; Vollrath D; Erger K; Wang W; Conlon T; Zhang K; Hauswirth W; Alkuraya FS
    Hum Genet; 2016 Mar; 135(3):327-43. PubMed ID: 26825853
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Advances in Ophthalmic Optogenetics: Approaches and Applications.
    Prosseda PP; Tran M; Kowal T; Wang B; Sun Y
    Biomolecules; 2022 Feb; 12(2):. PubMed ID: 35204770
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Restoring Color Perception to the Blind: An Electrical Stimulation Strategy of Retina in Patients with End-stage Retinitis Pigmentosa.
    Yue L; Castillo J; Gonzalez AC; Neitz J; Humayun MS
    Ophthalmology; 2021 Mar; 128(3):453-462. PubMed ID: 32858064
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Optogenetics-Mediated Gene Therapy for Retinal Diseases.
    Tomita H; Sugano E
    Adv Exp Med Biol; 2021; 1293():535-543. PubMed ID: 33398840
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In utero gene therapy rescues vision in a murine model of congenital blindness.
    Dejneka NS; Surace EM; Aleman TS; Cideciyan AV; Lyubarsky A; Savchenko A; Redmond TM; Tang W; Wei Z; Rex TS; Glover E; Maguire AM; Pugh EN; Jacobson SG; Bennett J
    Mol Ther; 2004 Feb; 9(2):182-8. PubMed ID: 14759802
    [TBL] [Abstract][Full Text] [Related]  

  • 36. AAV mediated GDNF secretion from retinal glia slows down retinal degeneration in a rat model of retinitis pigmentosa.
    Dalkara D; Kolstad KD; Guerin KI; Hoffmann NV; Visel M; Klimczak RR; Schaffer DV; Flannery JG
    Mol Ther; 2011 Sep; 19(9):1602-8. PubMed ID: 21522134
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Opsins for vision restoration.
    Simon CJ; Sahel JA; Duebel J; Herlitze S; Dalkara D
    Biochem Biophys Res Commun; 2020 Jun; 527(2):325-330. PubMed ID: 31982136
    [TBL] [Abstract][Full Text] [Related]  

  • 38. How Azobenzene Photoswitches Restore Visual Responses to the Blind Retina.
    Tochitsky I; Helft Z; Meseguer V; Fletcher RB; Vessey KA; Telias M; Denlinger B; Malis J; Fletcher EL; Kramer RH
    Neuron; 2016 Oct; 92(1):100-113. PubMed ID: 27667006
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Functionally specific optogenetic modulation in primate visual cortex.
    Chernov MM; Friedman RM; Chen G; Stoner GR; Roe AW
    Proc Natl Acad Sci U S A; 2018 Oct; 115(41):10505-10510. PubMed ID: 30257948
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Feasibility study for a glutamate driven subretinal prosthesis: local subretinal application of glutamate on blind retina evoke network-mediated responses in different types of ganglion cells.
    Haq W; Dietter J; Bolz S; Zrenner E
    J Neural Eng; 2018 Aug; 15(4):045004. PubMed ID: 29916398
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.